-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Silo Pharma, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2020 to Q3 2025.
- Silo Pharma, Inc. Cost of Revenue for the quarter ending September 30, 2025 was $20.7K, a 1318% increase year-over-year.
- Silo Pharma, Inc. Cost of Revenue for the twelve months ending September 30, 2025 was $25.1K, a 329% increase year-over-year.
- Silo Pharma, Inc. annual Cost of Revenue for 2024 was $5.84K, unchanged from 2023.
- Silo Pharma, Inc. annual Cost of Revenue for 2023 was $5.84K, unchanged from 2022.
- Silo Pharma, Inc. annual Cost of Revenue for 2022 was $5.84K, a 16.7% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)